JP2000504696A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000504696A5 JP2000504696A5 JP1997528821A JP52882197A JP2000504696A5 JP 2000504696 A5 JP2000504696 A5 JP 2000504696A5 JP 1997528821 A JP1997528821 A JP 1997528821A JP 52882197 A JP52882197 A JP 52882197A JP 2000504696 A5 JP2000504696 A5 JP 2000504696A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPN8012A AUPN801296A0 (en) | 1996-02-12 | 1996-02-12 | Stabilised growth hormone formulation and method of preparation thereof |
| PCT/AU1997/000075 WO1997029767A1 (en) | 1996-02-12 | 1997-02-12 | Stabilised growth hormone formulation and method of preparation thereof |
| AU8012 | 1998-06-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000504696A JP2000504696A (ja) | 2000-04-18 |
| JP2000504696A5 true JP2000504696A5 (enExample) | 2004-11-18 |
| JP4255515B2 JP4255515B2 (ja) | 2009-04-15 |
Family
ID=3792327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52882197A Expired - Lifetime JP4255515B2 (ja) | 1996-02-12 | 1997-02-12 | 安定化された成長ホルモン処方物およびその製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6593296B1 (enExample) |
| EP (1) | EP0889733B1 (enExample) |
| JP (1) | JP4255515B2 (enExample) |
| CN (1) | CN1132626C (enExample) |
| AT (1) | ATE340587T1 (enExample) |
| AU (1) | AUPN801296A0 (enExample) |
| CA (1) | CA2246501C (enExample) |
| DE (1) | DE69736739T2 (enExample) |
| DK (1) | DK0889733T3 (enExample) |
| RU (1) | RU2191029C2 (enExample) |
| TR (1) | TR199801558T2 (enExample) |
| WO (1) | WO1997029767A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277410B1 (en) * | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
| CN1360506A (zh) * | 1999-07-12 | 2002-07-24 | 格兰迪斯生物技术有限公司 | 生长激素配方 |
| AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| WO2001062296A2 (en) | 2000-02-24 | 2001-08-30 | Monsanto Technology Llc | Non-aqueous injectable formulations for extended release of somatotropin |
| MXPA03000073A (es) | 2000-06-26 | 2003-09-25 | Monsanto Technology Llc | Formulaciones que contienen agente tensioactivo no acuoso para la liberacion prolongada de somatrotopina. |
| US6664234B1 (en) | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| GB2371227A (en) * | 2001-01-10 | 2002-07-24 | Grandis Biotech Gmbh | Crystallisation - resistant aqueous growth hormone formulations |
| JP4610154B2 (ja) * | 2002-05-30 | 2011-01-12 | 大塚製薬株式会社 | 注射用製剤 |
| CN101659701B (zh) * | 2002-12-31 | 2019-03-26 | 阿尔特斯制药公司 | 人生长激素晶体和制备它们的方法 |
| US20060252682A1 (en) * | 2003-03-18 | 2006-11-09 | Ares Trading S.A. | Liquid growth hormone formulation and process of preparation thereof |
| WO2005027960A1 (en) * | 2003-09-25 | 2005-03-31 | Cangene Corporation | Liquid human growth hormone formulation containing polyethylene glycol |
| JP4845741B2 (ja) * | 2003-12-23 | 2011-12-28 | ファルマシア コーポレーション | 安定な成長ホルモン液体製剤 |
| ES2383994T3 (es) * | 2004-04-07 | 2012-06-28 | Ares Trading S.A. | Formulación líquida de hormona del crecimiento |
| EP1809663B1 (en) | 2004-11-09 | 2008-09-17 | Ares Trading S.A. | Method for purifying fsh |
| US20080219952A1 (en) | 2005-08-26 | 2008-09-11 | Ares Trading S.A. | Process For the Preparation of Glycosylated Interferon Beta |
| JP5199112B2 (ja) | 2005-12-09 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | Ｆｓｈ又はｆｓｈ変異体を精製するための方法 |
| LT2049148T (lt) * | 2006-07-06 | 2016-11-25 | Daewoong Co., Ltd. | Žmogaus augimo hormono skysta stabili kompozicija |
| CN105412910A (zh) * | 2006-07-06 | 2016-03-23 | 株式会社大熊 | 稳定的人生长激素液体制剂 |
| WO2009130181A2 (en) * | 2008-04-21 | 2009-10-29 | Novo Nordisk Health Care Ag | Dry transglutaminase composition |
| WO2013014196A1 (en) | 2011-07-25 | 2013-01-31 | Sandoz Ag | Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
| US10064951B2 (en) * | 2012-03-30 | 2018-09-04 | Hanmi Science Co., Ltd. | Liquid formulation of highly concentrated long-acting human growth hormone conjugate |
| CN105848645A (zh) * | 2013-09-27 | 2016-08-10 | 韩美药品株式会社 | 持续型人生长激素制剂 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB131864A (enExample) | ||||
| DE3325223A1 (de) * | 1983-07-13 | 1985-01-24 | Hoechst Ag, 6230 Frankfurt | Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung |
| EP0211601A3 (en) | 1985-07-30 | 1988-01-13 | International Minerals And Chemical Corporation | Stabilization of growth promoting hormones |
| IT1222395B (it) * | 1987-07-30 | 1990-09-05 | Pierrel Spa | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare |
| EP0303746B2 (en) | 1987-08-21 | 1998-12-02 | Mallinckrodt Group Inc. | Stabilization of growth promoting hormones |
| US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| EP0374120A3 (en) * | 1988-12-13 | 1991-07-31 | Monsanto Company | Comosition for controlled release of polypeptides |
| US5013714A (en) * | 1988-12-15 | 1991-05-07 | Lindstrom Richard L | Viscoelastic solution |
| US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
| US5182258A (en) * | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
| US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
| DK204791D0 (da) * | 1991-12-20 | 1991-12-20 | Novo Nordisk As | Hidtil ukendt farmaceutisk praeparat |
| SE9201073D0 (sv) | 1992-04-03 | 1992-04-03 | Kabi Pharmacia Ab | Protein formulation |
| DK0955062T3 (da) * | 1992-07-31 | 2007-09-17 | Genentech Inc | Vandig formulering indeholdende humant væksthormon |
| ATE198277T1 (de) * | 1992-10-02 | 2001-01-15 | Genetics Inst | Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator |
| DK0686045T3 (da) * | 1993-02-23 | 2001-03-05 | Genentech Inc | Stabilisering af med organisk opløsningsmiddel behandlede polypeptider med et hjælpestof |
| JPH09510182A (ja) * | 1993-11-17 | 1997-10-14 | エルディーエス・テクノロジーズ・インコーポレーテッド | カプセル封入されたドラッグデリバリー用透明液 |
-
1996
- 1996-02-12 AU AUPN8012A patent/AUPN801296A0/en not_active Abandoned
-
1997
- 1997-02-12 EP EP97902109A patent/EP0889733B1/en not_active Revoked
- 1997-02-12 TR TR1998/01558T patent/TR199801558T2/xx unknown
- 1997-02-12 JP JP52882197A patent/JP4255515B2/ja not_active Expired - Lifetime
- 1997-02-12 WO PCT/AU1997/000075 patent/WO1997029767A1/en not_active Ceased
- 1997-02-12 RU RU98117135/14A patent/RU2191029C2/ru active
- 1997-02-12 CA CA2246501A patent/CA2246501C/en not_active Expired - Fee Related
- 1997-02-12 CN CN97193316A patent/CN1132626C/zh not_active Expired - Fee Related
- 1997-02-12 DK DK97902109T patent/DK0889733T3/da active
- 1997-02-12 AT AT97902109T patent/ATE340587T1/de active
- 1997-02-12 US US09/125,267 patent/US6593296B1/en not_active Expired - Fee Related
- 1997-02-12 DE DE69736739T patent/DE69736739T2/de not_active Expired - Lifetime